Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
grn-1201 (2 trials)
pembrolizumab (keytruda) (1 trial)
Melanoma (Phase 1)
Trials (2 total)
Trial APIs (2 total)